Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, TRI

Advarra Launches Partner Network to Extend Research Capabilities and to Enable Site-Centric Connectivity Across the Industry


The Advarra Partner Network fosters innovation at scale through API, Data, and Strategic partnerships, implementing an open, standardized framework to connect solutions and workflows amongst industry stakeholders.

COLUMBIA, Md., May 17, 2022 /PRNewswire/ -- Advarra, the market leader in regulatory review solutions, research quality and compliance consulting services, and site-centric technologies, today announced the launch of the Advarra Partner Network, a standardized partnership program designed to extend the research capabilities of Advarra customers and facilitate integration across research technology providers. Comprised of Application Programming Interface (API), Data, and Strategic partnerships, the network formalizes collaborative processes already in place between Advarra and other industry vendors and offers a blueprint for additional providers to support and collaborate with Advarra's research community.

Advarra supports more than 50,000 investigators, 77,000 technology users, and 75,000 protocols across research sites and life sciences companies. By formalizing API, Data, and Strategic partnerships, Advarra empowers customers with a site-centric technology ecosystem to better support their goals, while improving data quality and efficiency of information exchange, as well as decentralized workflows. Ultimately, the program reinforces Advarra as the partner of choice for both customers and third-party industry vendors.

The API Partner Program allows technology vendors to connect with Advarra's technology platform and is further organized by Silver, Gold, and Platinum Tiers based on level of integration and implementation support. Recently established, the Data Partner Program augments Advarra's technology solutions, most notably Advarra's SiteIQ solution, with key patient, site, and sponsor data to drive better decision-making and collaboration. Lastly, the Strategic Partner Program encompasses additional offerings beyond exclusive technology use and will be a source of unique value for Advarra customers. All partners are rigorously evaluated to ensure their integrity, quality, and ability to satisfy specific use cases, and contribute to the overall ecosystem.

"As the industry continues to march toward vendors offering platforms rather than single point solutions, it's increasingly evident that APIs and other interfaces must be leveraged to reduce redundancy and ultimately allow specialized staff to focus on the patients we serve," said Benjamin Malmquist, Informatics Principal Lead at Novant Health, an Advarra Technology Customer. "Advarra's Partner Network has the potential to greatly influence the research technology community by extending the interoperability of their systems while removing tedious data entry and technical staffing needs for their customers. This is another example of how Advarra is supporting their customers' entire workflows beyond their own ecosystem."

"It's clear the industry needs a different approach. No single vendor can solve for research complexities on its own, so the industry needs a more standardized, integrated technology ecosystem to truly make the next leap in advancing research," said Gadi Saarony, Advarra's CEO. "Advarra has a long history of collaborating with vendors to support our customers; the Advarra Partner Network builds on that success by leveraging the Advarra Platform to connect with trusted partners to enable standardized connections at scale, creating unprecedented efficiencies to accelerate clinical trials."

Advarra is excited to welcome these inaugural partners to the Advarra Partner Network:

In addition to Advarra's newest partners, Advarra has a strong history of establishing integrations to better serve our customers. Namely, Advarra enables standardized EHR workflow integrations with top EHR providers, Epic and Cerner. Connections like these are critical to drive visibility between research and clinical care, as well as billing compliance and financial workflows.  "We're excited to extend our partnership and related efficiencies with technology companies and other vendors, enabling standardized integrations and connecting the overall research ecosystem," said Laura Hilty, VP of Strategy at Advarra. "Our new program allows us and our customers to drive more consistent and strategic outcomes, while opening new doors to what we can achieve at each individual site, and as an industry."

To learn more about the Advarra Partner Network, participating organizations, or to submit interest in becoming a partner, visit https://www.advarra.com/community/APN.

About Advarra

Advarra advances the way clinical research is conducted: bringing life sciences companies, CROs, research sites, investigators, and academia together at the intersection of safety, technology, and collaboration. With trusted review solutions, innovative technologies, experienced consultants, and deep-seated connections across the industry, Advarra provides integrated solutions that safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance. Advarra is advancing clinical trials to make them safer, smarter, and faster. For more information, visit advarra.com.

SOURCE Advarra


These press releases may also interest you

at 03:00
Todd Britten, DMD, a board-certified periodontist and dental implant specialist in...

at 03:00
SK chemicals (CEO Ahn Jae-hyun), Dongsung Chemical (Co-CEOs Baek Jin-woo and Lee Man-woo), and BYN Black Yak (Chairman Kang Tae-sun, hereinafter Black Yak) announced on the 18th that they've developed sustainable footwear materials using the...

at 02:55
First quarter  Sales of SEK 841 (854) million, a flat growth in local currencies and a decrease of 2% in SEK.Sales per region, in local currencies was +19% in APAC, -2% in EMEA and -14% in Americas.Sales per business area, in local currencies was...

at 02:05
PureTech Health plc ("PureTech" or the "Company") plans to publish its Annual Report and Accounts and financial results for the year ended December 31, 2023, on Thursday, April 25, 2024. A presentation and conference call to discuss the results...

at 02:05
Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced its business update and year-end report for January to March 2024. Highlights for the first quarter of 2024      Strong commercial...

at 01:30
The shares in Aker ASA will be traded ex-dividend NOK 15.50 as from today, 18 April 2024. Investor contact:Fredrik Berge, Head of Investor Relations Aker ASA Tel: +47 450 32 090 E-mail: [email protected] Media contact:Atle Kigen, Head of...



News published on and distributed by: